• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-125b 在多发性骨髓瘤发生发展中的作用机制研究。

The mechanism study of miR-125b in occurrence and progression of multiple myeloma.

机构信息

Department of Hematology, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010050, China.

出版信息

Cancer Med. 2018 Jan;7(1):134-145. doi: 10.1002/cam4.1181. Epub 2017 Dec 7.

DOI:10.1002/cam4.1181
PMID:29214735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5773953/
Abstract

Although many efforts have contributed to improve our knowledge of molecular pathogenesis about multiple myeloma (MM), the role and significance of microRNAs and long noncoding RNAs in MM cells, along with the core mechanism remains virtually absent. The mRNA levels of miR-125b and MALAT1 in MM cell lines were detected by qRT-PCR. The influence of Lenti-Sh-miR-125b on cell viability and the Notch-1 pathway-related proteins were assessed by MTT method and western blot, respectively. We also investigated the regulation effect between MALAT1 and Notch1 pathway. Moreover, the connection between Notch1 signaling and MM cell growth was discussed in-depth. The reverse effect of pcDNA-Notch1 on the cell viability and Notch-1 pathway proteins induced by Si-MALAT1 was also studied. Furthermore, miR-125b overexpressing MM cell lines were injected subcutaneously into nude mice. MiR-125b and MALAT1 were inversely expressed in MM cell lines. Lenti-Sh-miR-125b inhibited the expression of MALAT1 and Notch-1 protein. Binding sites were confirmed between miR-125b and MALAT1, and silencing MALAT1 did not alter the expression of Notch-1. The apoptosis rate was increased and the survival rate was decreased obviously in GSI XII (targeted cleavage of Notch-1 receptor) group, along with the inhibited Notch1 and HES1 proteins. Moreover, the decreased cell viability and Notch-1 pathway proteins induced by Si-MALAT1 could be reversed by pcDNA-Notch1. Lenti-Sh-miR-125b promoted survival and decreased Notch1 and HES1 proteins levels, while this effect was reversed by si -MALAT1. MiR-125b regulated MALAT1 expression via Notch1 signaling pathway to regulate cell growth, thus participating in the occurrence and progression of MM, which functioned as a therapeutic target for tracking MM.

摘要

尽管人们做出了许多努力来提高我们对多发性骨髓瘤(MM)分子发病机制的认识,但微 RNA 和长非编码 RNA 在 MM 细胞中的作用和意义,以及核心机制实际上仍然未知。qRT-PCR 检测 MM 细胞系中 miR-125b 和 MALAT1 的 mRNA 水平。MTT 法和 Western blot 分别评估 Lenti-Sh-miR-125b 对细胞活力和 Notch-1 通路相关蛋白的影响。我们还研究了 MALAT1 与 Notch1 通路之间的调节作用。此外,还深入探讨了 Notch1 信号与 MM 细胞生长之间的关系。还研究了 pcDNA-Notch1 对 Si-MALAT1 诱导的细胞活力和 Notch-1 通路蛋白的反向作用。进一步,将 miR-125b 过表达 MM 细胞系皮下注射到裸鼠中。MM 细胞系中 miR-125b 和 MALAT1 的表达呈负相关。Lenti-Sh-miR-125b 抑制 MALAT1 和 Notch-1 蛋白的表达。miR-125b 和 MALAT1 之间存在结合位点,沉默 MALAT1 不会改变 Notch-1 的表达。GSI XII(靶向 Notch-1 受体的切割)组中细胞凋亡率增加,存活率明显降低,同时 Notch1 和 HES1 蛋白受到抑制。此外,Si-MALAT1 诱导的细胞活力降低和 Notch-1 通路蛋白表达降低可被 pcDNA-Notch1 逆转。Lenti-Sh-miR-125b 促进存活并降低 Notch1 和 HES1 蛋白水平,而 Si-MALAT1 可逆转这种作用。miR-125b 通过 Notch1 信号通路调节 MALAT1 的表达,从而调节细胞生长,参与 MM 的发生和进展,可作为追踪 MM 的治疗靶点。

相似文献

1
The mechanism study of miR-125b in occurrence and progression of multiple myeloma.miR-125b 在多发性骨髓瘤发生发展中的作用机制研究。
Cancer Med. 2018 Jan;7(1):134-145. doi: 10.1002/cam4.1181. Epub 2017 Dec 7.
2
LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.长链非编码 RNA MALAT1/miR-181a-5p 通过调节 Hippo-YAP 信号通路影响骨髓瘤细胞的增殖和黏附。
Cell Cycle. 2019 Oct;18(19):2509-2523. doi: 10.1080/15384101.2019.1652034. Epub 2019 Aug 9.
3
LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway.长链非编码 RNA-MALAT1 通过竞争性结合 miR-424 来刺激 MEKK3/NF-κB 通路,从而促进婴儿血管瘤的肿瘤发生。
Life Sci. 2019 Dec 15;239:116946. doi: 10.1016/j.lfs.2019.116946. Epub 2019 Oct 11.
4
Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.长链非编码 RNA MALAT1 通过 microRNA-125b/STAT3 轴促进口腔鳞状细胞癌的发展。
J Cell Physiol. 2018 Apr;233(4):3384-3396. doi: 10.1002/jcp.26185. Epub 2017 Nov 20.
5
Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.抑制长链非编码 RNA MALAT1 通过减少 ZEB1 来提高 microRNA-429 抑制下咽鳞状细胞癌的进展。
Life Sci. 2020 Dec 1;262:118480. doi: 10.1016/j.lfs.2020.118480. Epub 2020 Sep 25.
6
LncRNA NEAT1 affects inflammatory response by targeting miR-129-5p and regulating Notch signaling pathway in epilepsy.长链非编码 RNA NEAT1 通过靶向 miR-129-5p 并调节癫痫中的 Notch 信号通路来影响炎症反应。
Cell Cycle. 2020 Feb;19(4):419-431. doi: 10.1080/15384101.2020.1711578. Epub 2020 Jan 17.
7
MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.MALAT1/miR-124/Capn4 轴调控鼻咽癌细胞的增殖、侵袭和 EMT。
Cancer Biol Ther. 2017 Oct 3;18(10):792-800. doi: 10.1080/15384047.2017.1373214. Epub 2017 Aug 31.
8
MicroRNA miR-188-5p as a mediator of long non-coding RNA MALAT1 regulates cell proliferation and apoptosis in multiple myeloma.微小 RNA miR-188-5p 作为长链非编码 RNA MALAT1 的介导物调节多发性骨髓瘤中的细胞增殖和凋亡。
Bioengineered. 2021 Dec;12(1):1611-1626. doi: 10.1080/21655979.2021.1920325.
9
Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis.长链非编码 RNA MALAT1 通过 miR-1271-5p/SOX13 轴促进多发性骨髓瘤的发生、侵袭和糖酵解。
J Cancer Res Clin Oncol. 2020 Feb;146(2):367-379. doi: 10.1007/s00432-020-03127-8. Epub 2020 Jan 18.
10
LncRNA 1 Regulates miR-144-3p to Facilitate Epithelial-Mesenchymal Transition of Lens Epithelial Cells via the ROS/NRF2/Notch1/Snail Pathway.长链非编码RNA 1通过ROS/NRF2/Notch1/蜗牛途径调控miR-144-3p以促进晶状体上皮细胞的上皮-间质转化
Oxid Med Cell Longev. 2020 Nov 12;2020:8184314. doi: 10.1155/2020/8184314. eCollection 2020.

引用本文的文献

1
A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma.关于微小RNA作为喉癌预后生物标志物的批判性综述
Int J Mol Sci. 2024 Dec 16;25(24):13468. doi: 10.3390/ijms252413468.
2
A comprehensive review of oncogenic Notch signaling in multiple myeloma.多发性骨髓瘤中致癌性Notch信号通路的综合综述。
PeerJ. 2024 Nov 28;12:e18485. doi: 10.7717/peerj.18485. eCollection 2024.
3
MicroRNA-125b as a valuable predictive marker for outcome after autologous hematopoietic stem cell transplantation.微小 RNA-125b 作为自体造血干细胞移植后预后的有价值的预测标志物。

本文引用的文献

1
MicroRNA-127 is a tumor suppressor in human esophageal squamous cell carcinoma through the regulation of oncogene FMNL3.微小RNA-127通过调控癌基因FMNL3在人食管鳞状细胞癌中发挥肿瘤抑制作用。
Eur J Pharmacol. 2016 Nov 15;791:603-610. doi: 10.1016/j.ejphar.2016.09.025. Epub 2016 Sep 17.
2
MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma.微小RNA-15a/16通过抑制多发性骨髓瘤中Bcl-2、血管内皮生长因子-A和白细胞介素-17的表达来调节骨髓瘤细胞的生长、血管生成和抗肿瘤免疫。
Leuk Res. 2016 Oct;49:73-9. doi: 10.1016/j.leukres.2016.08.013. Epub 2016 Aug 28.
3
BMC Cancer. 2023 Mar 3;23(1):202. doi: 10.1186/s12885-023-10665-0.
4
The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAs.多发性骨髓瘤全景:表观遗传学与非编码RNA
Cancers (Basel). 2022 May 10;14(10):2348. doi: 10.3390/cancers14102348.
5
Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells.多发性骨髓瘤干细胞样细胞的鉴定与特征分析
Cancers (Basel). 2021 Jul 14;13(14):3523. doi: 10.3390/cancers13143523.
6
The Emerging Roles of miR-125b in Cancers.微小RNA-125b在癌症中的新兴作用
Cancer Manag Res. 2020 Feb 12;12:1079-1088. doi: 10.2147/CMAR.S232388. eCollection 2020.
7
Long Non-Coding RNA in the Pathogenesis of Cancers.长链非编码 RNA 在癌症发病机制中的作用。
Cells. 2019 Sep 1;8(9):1015. doi: 10.3390/cells8091015.
8
MicroRNAs and their role in environmental chemical carcinogenesis.微小 RNA 及其在环境化学致癌中的作用。
Environ Geochem Health. 2019 Feb;41(1):225-247. doi: 10.1007/s10653-018-0179-8. Epub 2018 Aug 31.
Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics.
长链非编码RNA作为新型生物标志物在癌症诊断中有着广阔的前景。
Dis Markers. 2016;2016:9085195. doi: 10.1155/2016/9085195. Epub 2016 Apr 10.
4
Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.外泌体相关微小RNA谱及体内环境在预测多发性骨髓瘤患者耐药性中的潜在作用
Oncotarget. 2016 May 24;7(21):30876-91. doi: 10.18632/oncotarget.9021.
5
Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.多发性骨髓瘤细胞通过Notch/miR-223调节骨髓基质细胞的VEGF/IL-6水平和成骨潜能。
Mol Carcinog. 2016 Dec;55(12):1927-1939. doi: 10.1002/mc.22440. Epub 2015 Nov 24.
6
MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.微小RNA 100通过靶向雷帕霉素靶蛋白(mTOR),部分地使腔面A型乳腺癌细胞对紫杉醇治疗敏感。
Oncotarget. 2016 Feb 2;7(5):5702-14. doi: 10.18632/oncotarget.6790.
7
Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma.多发性骨髓瘤中长链非编码RNA KIAA0495的表观遗传沉默
Mol Cancer. 2015 Sep 26;14:175. doi: 10.1186/s12943-015-0444-8.
8
Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.用于预测多发性骨髓瘤患者生存的潜在预后lncRNA生物标志物的鉴定与验证
J Exp Clin Cancer Res. 2015 Sep 11;34(1):102. doi: 10.1186/s13046-015-0219-5.
9
Notch signaling: an emerging therapeutic target for cancer treatment.Notch信号通路:癌症治疗中一个新兴的治疗靶点。
Cancer Lett. 2015 Dec 1;369(1):20-7. doi: 10.1016/j.canlet.2015.07.048. Epub 2015 Sep 1.
10
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.通过合成的微小RNA-125b-5p模拟物对IRF4进行选择性靶向在体外和体内诱导抗多发性骨髓瘤活性。
Leukemia. 2015 Nov;29(11):2173-83. doi: 10.1038/leu.2015.124. Epub 2015 May 19.